{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:04:14Z","timestamp":1711670654578},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Peripheral blood mononuclear cells (PBMC) from HIV-infected seropositive (HIV+) but not from normal, seronegative (HIV-) individuals are known to produce anti-HIV antibodies in vitro, in the absence or presence of pokeweed mitogen (PWM). Previous studies showed that up to 20\u201340% of spontaneously immunoglobulin-secreting B cells from HIV+ individuals are HIV-specific. To analyse the frequency of anti-HIV B cells among \u201ctotal\u201d peripheral blood B cells in the present study, we used a limiting dilution assay in which EL-4 thymoma cells induce clones of immunoglobulln-secreting cells in activated as well as resting B cells. Anti-HIV B cells were detected not only in 11\/12 HIV+ individuals (with frequencies from 1\/910 lo 1\/21 500 B cells cultured; one negative test was from a person undergoing seroconversion), but also in 4\/9 HIV normal blood donors (1\/16200 to 1\/49000 B cells cultured) and in 3\/6 newborns from HIV mothers (1\/11 800 to l\/26 600 B cells cultured). The mean frequency was nine times higher in the HIV individuals than in the normal donors. As in previous studies, only the cells from HIV individuals generated anti-HIV antibodies in PBMC bulk cultures with or without PWM. The relative proportion of specific anti-HIV antibody total immunoglobulin in PBMC bulk cultures was 800 times higher by the mean than in EL-4 B cell cultures from HIV individuals (whereby the total immunoglobulin secretion for equal numbers of B cells cultured was 500 times lower for PBMC). These different results obtained with different assays suggest that in seropositives most anti-HIV B cells belong to an activated B compartment which is quite small, even in a disease with B cell hyperactivity. Therefore, the specific B cells are strongly diluted among the EL-4 cell-responsive, total B cells. On the other hand, the EL-4 assay can detect HIV-reactive B cells in the B ceil repertoire of normal, non-infected individuals.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1992.tb06409.x","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T21:42:33Z","timestamp":1280180553000},"page":"31-36","source":"Crossref","is-referenced-by-count":9,"title":["Frequencies of HIV-reactive B cells in seropositive and seronegative individuals"],"prefix":"10.1093","volume":"87","author":[{"given":"R H","family":"ZUBLER","sequence":"first","affiliation":[{"name":"Divisions of Haematology, H\u00f4pital Cantonal Universitaire, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L H","family":"PERRIN","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Department of Medicine, H\u00f4pital Cantonal Universitaire, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"DOUCET","sequence":"additional","affiliation":[{"name":"Divisions of Haematology, H\u00f4pital Cantonal Universitaire, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"ZHANG","sequence":"additional","affiliation":[{"name":"Divisions of Haematology, H\u00f4pital Cantonal Universitaire, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y-P","family":"HUANG","sequence":"additional","affiliation":[{"name":"Divisions of Haematology, H\u00f4pital Cantonal Universitaire, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P A","family":"MIESCHER","sequence":"additional","affiliation":[{"name":"Divisions of Haematology, H\u00f4pital Cantonal Universitaire, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011704040570000_b1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI112595","article-title":"Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders","volume":"78","author":"Yarchoan","year":"1986","journal-title":"J Clin Invest"},{"key":"2022011704040570000_b2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0167-5699(90)90144-X","article-title":"B-cell activation and HIV-1 infection: deeds and misdeeds","volume":"11","author":"Amadori","year":"1990","journal-title":"Immunol Today"},{"key":"2022011704040570000_b3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0167-5699(90)90070-P","article-title":"Immunopathogenic mechanisms of HIV infection: cytokine induction of IIIV expression","volume":"11","author":"Rosenberg","year":"1990","journal-title":"Immunol Today"},{"key":"2022011704040570000_b4","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.4049\/jimmunol.143.7.2146","article-title":"HIV-1-specific B cell activation: a major constituent of spontaneous B cell activation during HIV-1 infection","volume":"143","author":"Amadori","year":"1989","journal-title":"J Immunol"},{"key":"2022011704040570000_b5","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1073\/pnas.86.19.7532","article-title":"In vitro synthesis of human immunodeficiency virus-specific antibodies in peripheral blood lymphocytes of infants","volume":"86","author":"Pahwa","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011704040570000_b6","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1084\/jem.155.5.1561","article-title":"Human B cell differentiation, II, Pokeweed mitogen-responsive B cells belong to a surface immunoglobulin D-negative subpopulation","volume":"155","author":"Kuritani","year":"1982","journal-title":"J Exp Med"},{"key":"2022011704040570000_b7","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/eji.1830170624","article-title":"Limiting dilution assay for human B cells based on their activation by mutant EL-4 thymoma cells: total and anti-malaria responder B cell frequencies","volume":"17","author":"Wen","year":"1987","journal-title":"Eur J Immunol"},{"key":"2022011704040570000_b8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-065X.1987.tb01181.x","article-title":"Theoretical and practical aspects of B cell activation: murine and human systems","volume":"99","author":"Zubler","year":"1987","journal-title":"Immunol Rev"},{"key":"2022011704040570000_b9","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/eji.1830190709","article-title":"Cell surface antigen CD5 is a marker for activated human B cells","volume":"19","author":"Werner-Favre","year":"1989","journal-title":"Eur J Immunol"},{"key":"2022011704040570000_b10","first-page":"334","article-title":"Classification system for human T-lymphotropic virus type III\/lymphadenopathy-associated virus infections","volume":"35","author":"Centers for Disease Control.","year":"1986","journal-title":"MMWR"},{"key":"2022011704040570000_b11","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1084\/jem.171.5.1791","article-title":"Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells","volume":"171","author":"Tremblay","year":"1990","journal-title":"J Exp Med"},{"key":"2022011704040570000_b12","first-page":"389","article-title":"Are cord blood B cells immature","volume":"84","author":"Tucci","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"2022011704040570000_b13","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.4049\/jimmunol.147.9.3001","article-title":"Interleukin 4-dependent IgE switch in membrane IgA-positive human B cells","volume":"147","author":"Zhang","year":"1991","journal-title":"J Immunol"},{"key":"2022011704040570000_b14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1096\/fasebj.3.1.2562947","article-title":"AIDS: a syndrome of immune dysregulation, dysfunction, and deficiency","volume":"3","author":"Edelman","year":"1989","journal-title":"FASEB J"},{"key":"2022011704040570000_b15","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.4049\/jimmunol.144.8.2955","article-title":"Soluble factor- independent stimulation or human B cell response by mouse thymoma cells: Cyclosporine A-resistant and -sensitive cell contact signals","volume":"144","author":"Zhang","year":"1990","journal-title":"J Immunol"},{"key":"2022011704040570000_b16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1182\/blood.V77.1.133.133","article-title":"Autoantibodies against CD4 cells are associated with CD4 helper defects in human immunodeficiency virus-infected patients","volume":"77","author":"Weimer","year":"1991","journal-title":"Blood"},{"key":"2022011704040570000_b17","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1172\/JCI115059","article-title":"Transforming growth factor-\u03b2 and suppression of humoral immune responses in HIV infection","volume":"87","author":"Kekow","year":"1991","journal-title":"J Clin Invest"},{"key":"2022011704040570000_b18","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1172\/JCI114647","article-title":"A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythomatosus","volume":"85","author":"Tatal","year":"1990","journal-title":"J Clin Invest"},{"key":"2022011704040570000_b19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1126\/science.1701273","article-title":"Detection of a human intracisternal A-type retroviral particle antigenically related to HIV","volume":"250","author":"Garry","year":"1990","journal-title":"Science"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1992.tb06409.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/87\/1\/31\/42213352\/j.1365-2249.1992.tb06409.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/87\/1\/31\/42213352\/j.1365-2249.1992.tb06409.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T18:50:02Z","timestamp":1711651802000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/87\/1\/31\/6488260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,1]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1992.tb06409.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[1992,1]]},"published":{"date-parts":[[1992,1]]}}}